Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis Patients.
Modine T, Tchétché D, Van Mieghem N, Deeb G, Chetcuti S, Yakubov S, Sorajja P, Gada H, Mumtaz M, Ramlawi B, Bajwa T, Crouch J, Teirstein P, Kleiman N, Iskander A, Bagur R, Chu M, Berthoumieu P, Sudre A, Adrichem R, Ito S, Huang J, Popma J, Forrest J, Reardon M. Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis Patients. Circulation Cardiovascular Interventions 2024, e014018. PMID: 39421943, DOI: 10.1161/circinterventions.124.014018.Peer-Reviewed Original ResearchTranscatheter aortic valve replacementSelf-expanding transcatheter aortic valve replacementLow-risk patientsPatients aged <Society of Thoracic Surgeons Predicted Risk of MortalityRandomized to TAVRRate of severe prosthesis-patient mismatchSupra-annularThoracic Surgeons Predicted Risk of MortalityEvolut Low Risk TrialIncidence of disabling strokePatients treated with transcatheter aortic valve replacementRate of valve thrombosisSevere prosthesis-patient mismatchPatients treated with surgeryDisabling strokeIncidence of pacemaker implantationSevere aortic stenosis patientsRates of all-cause mortalityProsthesis-patient mismatchAortic valve replacementSevere aortic stenosisAortic stenosis patientsPatients to treatmentAll-cause mortalityFour-Year Outcomes After Transcatheter or Contemporary Surgical Aortic Valve Replacement from the Evolut Low Risk Trial
Ramlawi B, Deeb G, Mumtaz M, Bajwa T, Rovin J, Yakubov S, Jung Y, Reardon M, Forrest J. Four-Year Outcomes After Transcatheter or Contemporary Surgical Aortic Valve Replacement from the Evolut Low Risk Trial. Journal Of Thoracic And Cardiovascular Surgery 2024 PMID: 39181441, DOI: 10.1016/j.jtcvs.2024.08.023.Peer-Reviewed Original Research